Antheia, Inc. is a synthetic biology company focused on revolutionizing pharmaceutical manufacturing. By leveraging advanced biotechnology, the company produces biosynthetic Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs) to address drug shortages and create resilient pharmaceutical supply chains. Antheia's platform supports agile and sustainable production of essential medicines, enhancing scalability and equitability in drug distribution. Their innovative biomanufacturing processes reduce reliance on traditional agricultural sources, offering a more efficient and reliable alternative for complex pharmaceutical ingredient production.